Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019030262) HEMOPEXIN FORMULATIONS
Latest bibliographic data on file with the International BureauSubmit observation

Pub. No.: WO/2019/030262 International Application No.: PCT/EP2018/071465
Publication Date: 14.02.2019 International Filing Date: 08.08.2018
IPC:
A61P 7/04 (2006.01) ,A61K 38/16 (2006.01) ,A61K 38/17 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
7
Drugs for disorders of the blood or the extracellular fluid
04
Antihaemorrhagics; Procoagulants; Haemostatatic agents; Antifibrinolytic agents
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
Applicants:
CSL BEHRING AG [CH/CH]; Wankdorfstrasse 10 3014 Bern, CH
Inventors:
GENTINETTA, Thomas; CH
BRINKMAN, Nathan; US
BOEREMA, David; US
AN, Bo; US
MINER, Kyle; US
Agent:
BINSACK, Beate; DE
HAUSER, Hans-Peter; DE
LUDWIG, Holger; DE
PETER, Beate; DE
Priority Data:
62/542,66208.08.2017US
62/663,68627.04.2018US
Title (DE) HEMOPEXIN FORMULATIONS
(EN) HEMOPEXIN FORMULATIONS
(FR) FORMULATIONS D'HÉMOPEXINE
Abstract:
(DE) 1CSL Behring AG 2017_CH002_A272 PG/am 08.08.2018 ABSTRACT5 The present invention relates generally to a stable liquid formulation of purified hemopexin comprising: (a) a hemopexin content of at least 50 mg/mL; (b) at least 15 mM phosphate buffer;10 (c) a pH from 5.8 to 8; and (d) at least 50 mM sodium chloride; and uses thereof.
(EN) The present invention relates generally to a stable liquid formulation of purified hemopexin comprising: (a) a hemopexin content of at least 50 mg/mL; (b) at least 15 mM phosphate buffer; (c) a pH from 5.8 to 8; and (d) at least 50 mM sodium chloride; and uses thereof.
(FR) De manière générale, la présente invention concerne une formulation liquide stable d'hémopexine purifiée caractérisée par : (a) une teneur en hémopexine d'au moins 50 mg/mL ; (b) au moins 15 mM de tampon phosphate ; (c) un pH de 5,8 à 8 ; et (d) au moins 50 mM de chlorure de sodium ; et ses utilisations.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)